Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Paraoxonase 1 (PON1) C/T-108 association with longitudinal mean arterial blood pressure.

Bhatnagar V, Liu L, Nievergelt CM, Richard E, Brophy VH, Pandey B, Lipkowitz MS, O'Connor DT.

Am J Hypertens. 2012 Nov;25(11):1188-94. doi: 10.1038/ajh.2012.106. Epub 2012 Aug 2.

2.

Associations of PON1 and genetic ancestry with obesity in early childhood.

Huen K, Harley K, Beckman K, Eskenazi B, Holland N.

PLoS One. 2013 May 3;8(5):e62565. doi: 10.1371/journal.pone.0062565. Print 2013.

3.

Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis.

Rea IM, McKeown PP, McMaster D, Young IS, Patterson C, Savage MJ, Belton C, Marchegiani F, Olivieri F, Bonafe M, Franceschi C.

Exp Gerontol. 2004 Apr;39(4):629-35.

PMID:
15050299
4.

Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.

Campo S, Sardo MA, Trimarchi G, Bonaiuto M, Fontana L, Castaldo M, Bonaiuto A, Saitta C, Bitto A, Manduca B, Riggio S, Saitta A.

Exp Gerontol. 2004 Jul;39(7):1089-94.

PMID:
15236768
5.

The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults.

Voetsch B, Benke KS, Panhuysen CI, Damasceno BP, Loscalzo J.

Arch Neurol. 2004 Mar;61(3):351-6.

PMID:
15023811
6.

[Association of paraoxonase polymorphisms and serum homocysteine thiolactone complex with coronary heart disease].

Qin Q, Li YL, Zhao FM, Wang H, Li Y, Cui RZ, Zhao BR.

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Sep;34(9):803-7. Chinese.

PMID:
17217688
7.

Pesticides exposure and genetic polymorphism of paraoxonase in the susceptibility of Parkinson's disease.

Fong CS, Cheng CW, Wu RM.

Acta Neurol Taiwan. 2005 Jun;14(2):55-60.

PMID:
16008163
8.

[The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease].

Taşkiran P, Cam SF, Sekuri C, Tüzün N, Alioğlu E, Altintaş N, Berdeli A.

Turk Kardiyol Dern Ars. 2009 Oct;37(7):473-8. Turkish.

9.

Quantitative association between a newly identified molecular variant in the endothelin-2 gene and human essential hypertension.

Sharma P, Hingorani A, Jia H, Hopper R, Brown MJ.

J Hypertens. 1999 Sep;17(9):1281-7.

PMID:
10489105
10.

[Association between paraoxonase-1 and paraoxonase-2 polymorphisms and the risk of acute myocardial infarction].

Guxens M, Tomás M, Elosua R, Aldasoro E, Segura A, Fiol M, Sala J, Vila J, Fullana M, Sentí M, Vega G, de la Rica M, Marrugat J; investigadores del estudio IBERICA.

Rev Esp Cardiol. 2008 Mar;61(3):269-75. Spanish.

11.

Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.

Asefi M, Vaisi-Raygani A, Bahrehmand F, Kiani A, Rahimi Z, Nomani H, Ebrahimi A, Tavilani H, Pourmotabbed T.

Br J Dermatol. 2012 Dec;167(6):1279-86. doi: 10.1111/j.1365-2133.2012.11170.x.

PMID:
22835076
12.

The association of the paraoxonase (PON1) Q192R polymorphism with depression in older women: findings from the British Women's Heart and Health Study.

Lawlor DA, Day IN, Gaunt TR, Hinks LJ, Timpson N, Ebrahim S, Davey Smith G.

J Epidemiol Community Health. 2007 Jan;61(1):85-7.

13.

New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.

Marchesani M, Hakkarainen A, Tuomainen TP, Kaikkonen J, Pukkala E, Uimari P, Seppälä E, Matikainen M, Kallioniemi OP, Schleutker J, Lehtimäki T, Salonen JT.

J Natl Cancer Inst. 2003 Jun 4;95(11):812-8.

PMID:
12783936
14.

Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.

Kovács TJ, Harris S, Vas TK, Seres I, Short CD, Wittmann IK, Paragh G, Mackness MI, Mackness B, Durrington PN, Nagy JM, Brenchley PE.

J Nephrol. 2006 Nov-Dec;19(6):732-8.

PMID:
17173245
15.

Paraoxonase activity and genotype predispose to successful aging.

Marchegiani F, Marra M, Spazzafumo L, James RW, Boemi M, Olivieri F, Cardelli M, Cavallone L, Bonfigli AR, Franceschi C.

J Gerontol A Biol Sci Med Sci. 2006 Jun;61(6):541-6.

PMID:
16799134
16.

PON1 M/L55 mutation protects high-risk patients against coronary artery disease.

Oliveira SA, Mansur AP, Ribeiro CC, Ramires JA, Annichino-Bizzacchi JM.

Int J Cardiol. 2004 Mar;94(1):73-7.

PMID:
14996478
17.

Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.

Hussein YM, Gharib AF, Etewa RL, ElSawy WH.

Mol Cell Biochem. 2011 May;351(1-2):117-23. doi: 10.1007/s11010-011-0718-4. Epub 2011 Jan 13.

PMID:
21229382
18.
19.

[Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].

Chi DS, Ling WH, Ma J, Xia M, Hou MJ, Wang Q, Zhu HL, Tang ZH, Yu XP.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Jun;23(3):289-93. Chinese.

PMID:
16767666
20.

First survey of the three gene polymorphisms (PON1 Q192R, eNOS E298D and eNOS C-786T) potentially associated with coronary artery spasm in African populations and comparison with worldwide data.

Fujihara J, Yasuda T, Kawai Y, Morikawa N, Arakawa K, Koda Y, Soejima M, Kimura-Kataoka K, Takeshita H.

Cell Biochem Funct. 2011 Mar;29(2):156-63. doi: 10.1002/cbf.1721. Epub 2011 Feb 2.

PMID:
21287574

Supplemental Content

Support Center